Journal of pain and symptom management
-
J Pain Symptom Manage · Oct 2023
Post-Vaccine Era COVID-19 Pandemic-related Distress in Palliative Care Patients with Advanced Cancer.
The COVID-19 pandemic represents a source of distress in patients with advanced cancer; however, few studies have examined the extent of pandemic-related distress in the postvaccine era. ⋯ Patients with advanced cancer continued to experience pandemic-related distress in the postvaccine era. Our findings highlight potential opportunities to support patients.
-
J Pain Symptom Manage · Oct 2023
ReviewThe Experience of Black Patients with Serious Illness in the United States: A Scoping Review.
Black patients experience health disparities in access and quality of care. ⋯ More articles focused on establishing evidence of disparities between Black and White patients than on understanding their root causes. Further investigation is warranted to understand how factors at the patient, provider, health system, and society levels interact to remediate disparities.
-
J Pain Symptom Manage · Oct 2023
A core outcome set for interventions to prevent and/or treat delirium in palliative care.
Delirium is a serious neurocognitive syndrome which is highly prevalent in people approaching the end of life. Existing trials of interventions to prevent or treat delirium in adults receiving palliative care report heterogeneous outcomes. ⋯ Using a rigorous consensus process, we developed a core outcome set comprising four delirium-specific outcomes for inclusion in future trials of interventions to prevent and/or treat delirium in palliative care.
-
J Pain Symptom Manage · Oct 2023
Olanzapine for non-chemotherapy related nausea and emesis in patients with a palliative care consult.
Current palliative care guidelines lack a specific treatment algorithm for nausea and emesis. Olanzapine is an atypical antipsychotic with antiemetic activity that's recommended in the guidelines for the treatment of chemotherapy induced nausea and vomiting, but outside of oncologic indications there is a lack of research. ⋯ This retrospective review demonstrated benefit to utilizing olanzapine for nausea and emesis in palliative care patients and should be considered to aid in symptom management.
-
J Pain Symptom Manage · Oct 2023
Letter Case ReportsHiccups at the end of life in Parkinson's disease: a case report.